Clindamycin Hydrochloride
規格
21462-39-5CAS番号
244-398-6EC番号
(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochlorideIUPAC名
C18H34Cl2N2O5S化学式
461.4 g/mol分子量
Clindamycin hydrochloride; 21462-39-5; Clindamycin Hcl; Clinsol; Clintabs; Antirobe; Cleocin hydrochloride; DTXSID4045428; T20OQ1YN1W; Clindamycin (as hydrochloride); NSC-756696; DTXCID2025428; 7-Chloro-7-deoxylincomycin hydrochloride; NSC305832; ClindaCure; ClindaMed; ZydaClin; Antirobe Capsules; Antirobe Aquadrops; Clinamycin Hydrochloride; RefChem:54848; CLINDA-GUARD DROPS; Hydrochloride, Clindamycin; Clindamycin HCl Oral drops; Clindamycin Hydrochloride Oral Drops; Clindamycin Hydrochloride Oral Liquid; 244-398-6; Methyl 7-chloro-6,7,8-trideoxy-6-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside monohydrochloride; Sobelin; Cis-Clindamycin Hydrochloride; MFCD07793327; Clindamycin (hydrochloride); Cleocin; Dalacin C; (2S,4R)-N-((1S,2S)-2-CHLORO-1-((2R,3R,4S,5R,6R)-3,4,5-TRIHYDROXY-6-(METHYLTHIO)TETRAHYDRO-2H-PYRAN-2-YL)PROPYL)-1-METHYL-4-PROPYLPYRROLIDINE-2-CARBOXAMIDE HYDROCHLORIDE; EINECS 244-398-6; BenzaClin; C18H34Cl2N2O5S; (7S)-7-Chloro-7-deoxylincomycin hydrochloride; (2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride; Antirobe vet.; Cleocin HCl; U-21251F; 21462-39-5 (HCl); NCGC00016752-01; Clindamycin HCl (Dalacin); UNII-T20OQ1YN1W; Cleocin hydrochloride (TN); SCHEMBL3153; CAS-21462-39-5; Clindamycin hydrochloride RS; Clindamycin hydrochloride CRS; HY-B0408AR; MSK7803A; orb1222514; orb1300760; CHEMBL1200588; HY-B0408A; Clindamycin hydrochloride - 94%; CHEBI:176915; MSK7803A-100M; MSK7803A-1000M; Tox21_110591; EBC-98077; HB4364; CLINDAMYCIN HYDROCHLORIDE [MI]; AKOS015843964; AKOS015960823; Clindamycin hydrochloride (JP17/USP); AC07735; CCG-269349; Clindamycin (hydrochloride) (Standard); CLINDAMYCIN HYDROCHLORIDE [JAN]; NSC 756696; CLINDAMYCIN HYDROCHLORIDE [MART.]; CLINDAMYCIN HYDROCHLORIDE [VANDF]; AC-12179; AC178993; AS-13649; CLINDAMYCIN HYDROCHLORIDE [USP-RS]; Clindamycin hydrochloride [USP:BAN:JAN]; CLINDAMYCIN HYDROCHLORIDE [WHO-DD]; CLINDAMYCIN HYDROCHLORIDE ANHYDROUS; SY006928; U 21251F; Clindamycin 1000 microg/mL in Acetonitrile; C4532; NS00076311; T6448; 7(S)-Chloro-7-deoxylincomycin hyddrochloride; CLINDAMYCIN HYDROCHLORIDE [GREEN BOOK]; CLINDAMYCIN HYDROCHLORIDE [EP MONOGRAPH]; CLINDAMYCIN HYDROCHLORIDE [ORANGE BOOK]; D02132; EC 244-398-6; CLINDAMYCIN HYDROCHLORIDE [USP MONOGRAPH]; Clindamycin hydrochloride, lincosamide antibiotic; F036526; F554440; Q27289558; Clindamycin hydrochloride Solution in Methanol, 100ug/mL; (7S)-7-Chloro-7-deoxylincomycin hydrochloride monohydrate; Clindamycin hydrochloride Solution in Methanol, 1000ug/mL; Clindamycin hydrochloride, European Pharmacopoeia (EP) Reference Standard; (2S,4R)-N-((1S,2S)-2-CHLORO-1-((2R,3R,4S,5R,6R)-3,4,5-TRIHYDROXY-6-(METHYLTHIO)TETRAHYDRO-2H-PYRAN-2-YL)PROPYL)-1-METHYL-4-PROPYLPYRROLIDINE-2-CARBOXAMIDEHYDROCHLORIDE; (2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride; (4R)-N-[(1S,2S)-2-Chloro-1-[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride; L-THREO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE, METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-(((1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-THIO-,(2S-TRANS)-, MONOHYDROCHLORIDE; L-threo-|_-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, hydrochloride (1:1); L-threo-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-((((2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, monohydrochloride; L-threo-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, (2S-trans)-, monohydrochloride; L-threo-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-L-2-pyrrolidinyl)carbonyl)amino)-1-thio-, monohydrochloride, trans-alpha-; L-threo-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, hydrochloride (1:1); METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-(1-METHYL-TRANS-4-PROPYL-L-2-PYRROLIDINECARBOXAMIDO)-1-THIO-L-THREO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE MONOHYDROCHLORIDE; Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside monohydrochloride; Methyl 7-chloro-6,7,8-trideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-1-thio-L-threo-alpha-D-galacto-octopyranoside--hydrogen chloride (1/1); Methyl-7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-L-threo-alpha-D-galacto-octopyranoside hydrochloride別名
Clindamycin Hydrochlorideを含む製品
다마이신캡슐300밀리그램(클린다마이신염산염)(수출용)마더스클린다마이신캡슐300mg(클린다마이신염산염)(수출용)클리신캡슐300밀리그램(클린다마이신염산염)(수출용)클리신캡슐(클린다마이신염산염)(수출용)성원애드콕클린다마이신염산염캡슐300mg(수출용)바이오스마이신캡슐(염산클린다마이신)(수출용)위더스염산클린다마이신캡슐300mg(수출명:Withus Clindamycin Capsule 300mg)(수출용)위더스염산클린다마이신캡슐150mg (수출명:Withus Clindamycin Capsule 150mg) (수출용)크라미세프캡슐300mg(염산클린다마이신)(수출용)크라미세프캡슐(클린다마이신염산염)(수출용)린다론캡슐300밀리그램(클린다마이신염산염)(수출용)클리마이신캡슐150mg(클린다마이신염산염)(수출용)
1/7ページ
Clindamycin Hydrochlorideを販売する企業
(주
(주)동구바이오제약Republic of Korea삼진
삼진제약(주)Republic of Korea유니
유니메드제약(주)Republic of KoreaAP
Aurobindo Pharma LimitedIndia1/5ページ